Hertz Global And Webull Stocks Are Among Top Mid-Cap Gainers Last Week (Apr 14-Apr 18): Are The Others In Your Portfolio?
Notable Healthcare Headlines for the Week: UnitedHealth, Eli Lilly, J&J in Focus
Pfizer Inc. (PFE): Among Jeff Smith's Top Activist Targets
Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic's Competition Grows -- Barrons.com
Catalyst Watch: Spotlight on Tesla, Alphabet Earnings, AACR Drug Data, and Global PMI Reports
Daily short sale tracking: Petroleo Brasileiro SA Petrobras's short volume increased by 3 million, with a short sale ratio of 21%
BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $30
Pfizer (PFE) Laps the Stock Market: Here's Why
Pfizer Options Spot-On: On April 17th, 119.96K Contracts Were Traded, With 3.51 Million Open Interest
SA Asks: What's the Best Weight-loss Drug Stock Right Now?
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
Is Pfizer Inc. (PFE) the Best Large-Cap Value Stock to Buy as the Recession Hits?
Children's Hospital of Philadelphia Researchers Find Gene Therapy Shows Long-Term Benefits for Hemophilia B Patients
US stocks volatility | Eli Lilly and Co (LLY.US) surged 13% in pre-market trading after positive results from the phase 3 trial of its oral weight loss medication.
The Eli Lilly and Co trial showed that the oral medication orforglipron reduces body weight by nearly 8% in patients with type 2 diabetes at the highest dosage, and it also lowers blood sugar.
Eli Lilly's Oral GLP-1 Drug Orforglipron Hits Phase 3 Goals In Diabetes Trial, Stock Soars
Express News | Pfizer : BMO Cuts Target Price to $30 From $36
It Looks Like Pfizer Inc.'s (NYSE:PFE) CEO May Expect Their Salary To Be Put Under The Microscope
Pfizer Says US CDC Panel Votes to Expand Recommendation for RSV Vaccine
Pfizer Options Spot-On: On April 16th, 125.91K Contracts Were Traded, With 3.49 Million Open Interest
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction